Back
Product details:
ID
CAS
1197953-54-0
Purity
95%
Brigatinib is an anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.
Properties
Name
Brigatinib
Smiles
COC=1C=C(C=CC1NC=2N=CC(Cl)=C(NC=3C=CC=CC3P(=O)(C)C)N2)N4CCC(CC4)N5CCN(C)CC5
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
AP26113 | alunbrig | brigatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
AP26113 | alunbrig | brigatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.